SCHEMBL31061476

SCHEMBL31061476

CCCCn1cnc2c(NCc3ccccc3)nc(C#N)nc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CTSL P07711 20/20 1.00
CTSB P07858 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17450142 0.81 CTSL (0.67) CTSL
SCHEMBL6817859 0.79 CDK1 (0.74) CTSL
SCHEMBL28232529 0.76 CDK2 (0.89) CTSL
SCHEMBL20350685 0.74 CDK1 (0.73) CTSL
SCHEMBL17628578 0.73 CDK1 (0.65) CTSL
SCHEMBL28771447 0.73 PPARD (0.64) CTSL
SCHEMBL3380592 0.73 NPC1 (0.76) CTSLCTSB
SCHEMBL27734468 0.72 TMIGD3 (1.00) CTSL
SCHEMBL15281232 0.72 CTSL (1.00) CTSLCTSB
SCHEMBL17450128 0.71 CDK1 (0.60) CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed